Correlation Between West Pharmaceutical and Fonar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Fonar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Fonar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and Fonar, you can compare the effects of market volatilities on West Pharmaceutical and Fonar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Fonar. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Fonar.

Diversification Opportunities for West Pharmaceutical and Fonar

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between West and Fonar is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Fonar in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fonar and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Fonar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fonar has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Fonar go up and down completely randomly.

Pair Corralation between West Pharmaceutical and Fonar

Considering the 90-day investment horizon West Pharmaceutical Services is expected to under-perform the Fonar. But the stock apears to be less risky and, when comparing its historical volatility, West Pharmaceutical Services is 1.05 times less risky than Fonar. The stock trades about 0.0 of its potential returns per unit of risk. The Fonar is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,665  in Fonar on September 6, 2024 and sell it today you would lose (40.00) from holding Fonar or give up 2.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

West Pharmaceutical Services  vs.  Fonar

 Performance 
       Timeline  
West Pharmaceutical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Fonar 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fonar has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Fonar is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

West Pharmaceutical and Fonar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with West Pharmaceutical and Fonar

The main advantage of trading using opposite West Pharmaceutical and Fonar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Fonar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fonar will offset losses from the drop in Fonar's long position.
The idea behind West Pharmaceutical Services and Fonar pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.